Key facts
- This page summarizes Brian Knaley's Form 4 filing for Surna Inc. (CEAD).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 29 Jun 2021, 10:19.
Brian Knaley - 28 Jun 2021 Form 4 Insider Report for Surna Inc. (CEAD)
- Reporting relationship
- CFO/Treasurer, Director
- Issuer ticker
- CEAD
- Reported as of
- 28 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Jun 2021, 10:19:26 UTC
- Next SEC filing
- 02 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ R. Brian Knaley
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian Knaley filed Form 4 for Surna Inc. (CEAD) on 29 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CEAD
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- Shares
- +250,000
- Change %
- Price
- Shares after
- 250,000
- Date
- 28 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 250,000
- Exercise price
- $0.0610
- Footnotes
- F1
CEAD
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- Shares
- +417,000
- Change %
- Price
- Shares after
- 417,000
- Date
- 28 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 417,000
- Exercise price
- $0.0610
- Footnotes
- F2
CEAD
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- Shares
- +665,000
- Change %
- Price
- Shares after
- 665,000
- Date
- 28 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 665,000
- Exercise price
- $0.0610
- Footnotes
- F3
CEAD
transaction
Derivative
Option to purchase common stock
Award
- Transaction value
- Shares
- +668,000
- Change %
- Price
- Shares after
- 668,000
- Date
- 28 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 668,000
- Exercise price
- $0.0610
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which were vested and exercisable on the date of grant. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
Footnote F2
Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2022. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
Footnote F3
Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2023. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.
Footnote F4
Represents the grant of non-qualified stock options to purchase 250,000 shares of common stock at an exercise price of $0.061, the closing price of Issuer's common stock on June 25, 2021, which vest and become exercisable on June 30, 2024. These options were granted in connection with the Reporting Person's appointment as the Company's CEO and President. The grant of these options and the issuance of shares of common stock upon exercise are transactions exempt from Section 16(b) of the Exchange Act.